Cigna Group Balance Sheet Health
Financial Health criteria checks 2/6
Cigna Group has a total shareholder equity of $42.3B and total debt of $33.8B, which brings its debt-to-equity ratio to 79.9%. Its total assets and total liabilities are $157.6B and $115.3B respectively. Cigna Group's EBIT is $6.9B making its interest coverage ratio 4.6. It has cash and short-term investments of $6.8B.
Key information
79.9%
Debt to equity ratio
US$33.81b
Debt
| Interest coverage ratio | 4.6x |
| Cash | US$6.75b |
| Equity | US$42.30b |
| Total liabilities | US$115.34b |
| Total assets | US$157.64b |
Recent financial health updates
These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well
Oct 14
Cigna Group (NYSE:CI) Has A Somewhat Strained Balance Sheet
Jun 14We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt
Jan 25Recent updates
Cigna And The Risk Of PBMs - I'm Staying Out Above $230/Share
Dec 13These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well
Oct 14Cigna: This Dividend Grower Could Be Worth Buying Now
Sep 26Returns On Capital Are Showing Encouraging Signs At Cigna Group (NYSE:CI)
Sep 26Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'
Sep 19The Price Is Right For The Cigna Group (NYSE:CI)
Sep 08Cigna Group: Services Focus Leads To Outperformance
Jul 29Cigna: Game Over For PBMs?
Jul 12Cigna Group (NYSE:CI) Has A Somewhat Strained Balance Sheet
Jun 14Cigna: Will Benefit From Lower Medicaid Enrollments
Jun 11The Cigna Group (NYSE:CI) Not Lagging Market On Growth Or Pricing
May 27Cigna: An Up-And-Coming Dividend Growth Stock To Buy Now
May 13Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture
May 09Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being
Apr 18Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why
Apr 09Returns Are Gaining Momentum At Cigna Group (NYSE:CI)
Apr 05Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018
Apr 01Cigna: Trimming The Fat And Staying Focused
Mar 05Cigna: Big Buybacks And Total Return Potential
Feb 26Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40
Feb 05Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap
Jan 29We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt
Jan 25Why Dividend Growth Investors Should Buy Cigna
Jan 18It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)
Jan 09Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital
Dec 25Cigna: Sentiment And Fundamentals On Their Side
Dec 21Cigna's Merger Fumble: A Festive Financial Rebound
Dec 11Humana And Cigna Topple On Rumors Of An Unlikely Union
Nov 30Cigna Delivering Growth At A Great Price
Nov 13Cigna: Too Cheap To Ignore
Oct 24Cigna: Buy Rating Driven By Undervaluation & Revenue Growth
Oct 01Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape
Sep 14Cigna Group: Weaker Than Peers But Still A Buy
Aug 27Cigna: Buy During The Next Correction (Technical Analysis)
Aug 08Cigna: Buy While It's Still Cheap And Not Loved
Jun 29Cigna: Buy This Value Gem Before It Bounces Back
Jun 12Financial Position Analysis
Short Term Liabilities: CI's short term assets ($49.2B) do not cover its short term liabilities ($57.1B).
Long Term Liabilities: CI's short term assets ($49.2B) do not cover its long term liabilities ($58.3B).
Debt to Equity History and Analysis
Debt Level: CI's net debt to equity ratio (64%) is considered high.
Reducing Debt: CI's debt to equity ratio has reduced from 86.4% to 79.9% over the past 5 years.
Debt Coverage: CI's debt is not well covered by operating cash flow (19.6%).
Interest Coverage: CI's interest payments on its debt are well covered by EBIT (4.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 04:44 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
The Cigna Group is covered by 48 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Hua Ha | Baird |
| Ishan Majumdar | Baptista Research |